STOCK TITAN

Stryker Corporation (SYK) Financials

SYK NYSE
Trailing 12 months to September 30, 2026
Revenue $26.3B +7.9% YoY
Net Income $3.6B +23.1% YoY
EPS (Diluted) $9.39 +23.4% YoY
Free Cash Flow $4.6B +12.3% YoY
Market Cap $121.1B as of Nov 18, 2026
Price / Sales 4.6x on $26.3B revenue, trailing 12 months to September 30, 2026
Price / Earnings 33.4x on $3.6B net income, trailing 12 months to September 30, 2026
Price / Book 5.2x on $23.5B equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 18, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q3 FY2026, filed Oct 30, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SYK SEC filings page.

Stryker Corporation (SYK) reported $26.3B in revenue over the twelve months to Sep 30, 2026, up 7.9% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SYK FY2025

Stryker turns revenue growth into cash efficiently, while financing and tax costs increasingly separate operating gains from net income.

From FY2023 to FY2025, operating income rose 25.7% while net income rose only 2.6%. The widening gap coincided with interest expense rising 63.5% and income-tax expense rising 149.6%, so operating progress is outpacing reported earnings.

Operating cash flow reached $5.04B against net income of $3.25B, indicating accounting profit translated into cash rather than being tied up in working capital. Free cash flow reached $4.28B after $761M of capital expenditures, showing reinvestment consumed a limited share of internally generated cash.

Debt rose 21.9% in FY2025 while assets rose 11.3%, indicating balance-sheet expansion relied partly on additional borrowing. Debt-to-equity was 0.7x and liabilities were 53.1% of assets, a leveraged but not debt-dominated funding structure.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 69 / 100
Financial Health Score 69/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Stryker Corporation's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
83

Profitability ranks operating companies on their operating margin with gains on asset sales taken out, averaged over the last three fiscal years with the newest counting most, and in smaller part on how steady that margin has been. Stryker Corporation scores 83/100 on it among other operating companies.

Growth
66

Growth ranks operating companies on the yearly rate at which revenue compounded across the last three fiscal years (the last two where the earliest reports no revenue), counted in the currency each company reports in so that a move in the exchange rate is not read as growth. Stryker Corporation scores 66/100 on it among other operating companies.

Leverage
48

Stryker Corporation's net debt of $10.8B, being $14.9B of long-term debt less $4.0B of cash, came to 1.68 times its EBITDA in fiscal year 2025. Operating companies are ranked here on long-term debt less cash against their EBITDA, where a lower multiple is the safer one, and Stryker Corporation scores 48/100 among other operating companies measured the same way.

Liquidity
57

Stryker Corporation held $1.89 of current assets for every $1 of current liabilities at the end of fiscal year 2025, a current ratio of 1.89. Liquidity ranks operating companies on that ratio, and Stryker Corporation scores 57/100 among other operating companies.

Cash Flow
80

Cash Flow ranks operating companies on their free cash flow margin, which is operating cash flow less capital spending as a share of revenue, averaged over the last three fiscal years with the newest weighted most. Stryker Corporation scores 80/100 on it among other operating companies.

Returns
77

Returns ranks operating companies on their return on capital employed, which is operating income against total assets less current liabilities, averaged over three fiscal years with the newest weighted most, and in smaller part on how steady that return has been. Stryker Corporation scores 77/100 on it among other operating companies.

Altman Z-Score Safe
4.49

Stryker Corporation scores 4.49, well above the 2.99 safe threshold. The largest contribution to the score comes from a market capitalization of $121.1B against total liabilities of $25.4B. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral
4/9

Stryker Corporation passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 operating efficiency signals passes.

Earnings Quality Cash-Backed
1.55x

For every $1 of reported earnings, Stryker Corporation generates $1.55 in operating cash flow ($5.0B OCF vs $3.2B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe
8.40x

Stryker Corporation earns $8.40 in operating income for every $1 of interest expense ($4.9B vs $582.0M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$6.5B
YoY+7.6%
QoQ-1.0%
5Y CAGR+9.4%
10Y CAGR+8.7%

Stryker Corporation generated $6.5B in revenue in Q3 2026. This represents an increase of 7.6% from the same quarter a year earlier. Against the prior quarter it is down 1.0%.

EBITDA
$1.4B
YoY-6.9%
QoQ-30.6%

Stryker Corporation's EBITDA was $1.4B in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 6.9% from the same quarter a year earlier. Against the prior quarter it is down 30.6%.

Net Income
$753.0M
YoY-12.3%
QoQ-41.0%
5Y CAGR+11.4%
10Y CAGR+7.8%

Stryker Corporation reported $753.0M in net income in Q3 2026. This represents a decrease of 12.3% from the same quarter a year earlier. Against the prior quarter it is down 41.0%.

EPS (Diluted)
$1.96
YoY-11.7%
QoQ-40.6%
5Y CAGR+11.4%
10Y CAGR+7.6%

Stryker Corporation earned $1.96 per diluted share (EPS) in Q3 2026. This represents a decrease of 11.7% from the same quarter a year earlier. Against the prior quarter it is down 40.6%.

Cash & Balance Sheet

Free Cash Flow
$1.2B
YoY-9.5%
QoQ+15.6%
5Y CAGR+8.8%
10Y CAGR+12.3%

Stryker Corporation generated $1.2B in free cash flow in Q3 2026, representing cash available after capex. This represents a decrease of 9.5% from the same quarter a year earlier. Against the prior quarter it is up 15.6%.

Cash & Debt
$3.3B
YoY+0.5%
QoQ-3.5%
5Y CAGR+5.0%
10Y CAGR+1.0%

Stryker Corporation held $3.3B in cash against $14.2B in long-term debt as of Q3 2026.

Dividends Per Share
$0.88
YoY+4.8%
QoQ0.0%
5Y CAGR+6.9%
10Y CAGR+8.8%

Stryker Corporation paid $0.88 per share in dividends in Q3 2026. This represents an increase of 4.8% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding
381M
YoY-0.5%
QoQ-0.8%
5Y CAGR+0.2%
10Y CAGR+0.2%

Stryker Corporation had 381M shares outstanding in Q3 2026. This represents a decrease of 0.5% from the same quarter a year earlier. Against the prior quarter it is down 0.8%.

Margins & Returns

Gross Margin
65.1%
YoY+1.5pp
QoQ-3.1pp
5Y change+1.6pp
10Y change-1.0pp

Stryker Corporation's gross margin was 65.1% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is up 1.5 percentage points from the same quarter a year earlier. Against the prior quarter it is down 3.1 percentage points.

Operating Margin
15.9%
YoY-2.9pp
QoQ-9.3pp

Stryker Corporation's operating margin was 15.9% in Q3 2026, reflecting core business profitability. This is down 2.9 percentage points from the same quarter a year earlier. Against the prior quarter it is down 9.3 percentage points.

Net Margin
11.6%
YoY-2.6pp
QoQ-7.8pp
5Y change+1.0pp
10Y change-1.0pp

Stryker Corporation's net profit margin was 11.6% in Q3 2026, showing the share of revenue converted to profit. This is down 2.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 7.8 percentage points.

Return on Equity
3.2%
YoY-0.7pp
QoQ-2.1pp
5Y change+0.1pp
10Y change-0.6pp

Stryker Corporation's quarterly ROE was 3.2% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is down 0.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.1 percentage points.

Capital Allocation

R&D Spending
$433.0M
YoY+5.6%
QoQ-0.2%

Stryker Corporation invested $433.0M in research and development in Q3 2026. This represents an increase of 5.6% from the same quarter a year earlier. Against the prior quarter it is down 0.2%.

Capital Expenditures
$237.0M
YoY+26.7%
QoQ+17.3%
5Y CAGR+12.8%
10Y CAGR+7.2%

Stryker Corporation invested $237.0M in capex in Q3 2026, funding long-term assets and infrastructure. This represents an increase of 26.7% from the same quarter a year earlier. Against the prior quarter it is up 17.3%.

Share Buybacks

Not reported for Q3 2026.

SYK Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SYK quarterly income statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Revenue$6.5B+7.6%$6.6B+9.4%$6.0B+2.6%$7.2B+11.4%$6.1B+10.2%$6.0B+11.1%$5.9B+11.9%$6.4B+10.7%
Cost of Revenue$2.3B+3.0%$2.1B-4.1%$2.2B+4.1%N/A$2.2B+11.5%$2.2B+8.7%$2.1B+11.1%N/A
Gross Profit$4.2B+10.3%$4.5B+17.1%$3.8B+1.8%$4.6B+10.9%$3.9B+9.5%$3.8B+12.4%$3.7B+12.3%$4.2B+12.7%
R&D Expenses$433.0M+5.6%$434.0M+6.6%$413.0M+2.0%N/A$410.0M+8.8%$407.0M+12.1%$405.0M+10.1%N/A
SG&A Expenses$2.3B+13.1%$2.2B+7.2%$2.3B-0.8%N/A$2.0B+8.0%$2.1B+13.5%$2.3B+25.2%N/A
Operating Income$1.0B-8.9%$1.7B+49.1%$936.0M+11.8%N/A$1.1B+4.6%$1.1B+5.9%$837.0M-13.9%N/A
EBITDA$1.4B-6.9%$2.1B+37.5%$1.3B+11.3%N/A$1.5B+5.6%$1.5B+6.8%$1.2B-9.7%N/A
Interest Expense$137.0M-12.7%$136.0M-14.5%$142.0M+7.6%N/A$157.0M+60.2%$159.0M+65.6%$132.0MN/A
Income Tax$244.0M+43.5%$288.0M+118.2%$105.0M-4.5%N/A$170.0M-18.7%$132.0M-23.7%$110.0M-18.5%N/A
Net Income$753.0M-12.3%$1.3B+44.3%$745.0M+13.9%$849.0M+55.5%$859.0M+3.0%$884.0M+7.2%$654.0M-17.0%$546.0M-52.2%
EPS (Basic)$1.97-12.4%$3.32+43.1%$1.95+14.0%$2.21+54.5%$2.25+3.2%$2.32+6.9%$1.71-17.4%$1.43-52.5%
EPS (Diluted)$1.96-11.7%$3.30+44.1%$1.93+14.2%$2.20+56.0%$2.22+2.8%$2.29+7.0%$1.69-17.6%$1.41-52.7%
Diluted Shares (Avg)385M-0.5%386M-0.1%387M0.0%N/A387M+0.3%386M+0.3%386M+0.3%N/A

SYK Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SYK quarterly balance sheet
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'25FilingQ4'2410-K
Total Assets$47.2B+0.4%$47.9B+3.5%$46.3B+0.6%$47.8B+11.3%$47.1B+7.4%$46.3B+18.4%$46.0B+16.8%$43.0B+7.7%
Current Assets$14.2B+3.4%$14.4B+10.9%$13.3B+2.4%$14.8B-0.6%$13.7B-6.6%$13.0B+11.7%$13.0B+9.5%$14.8B+18.6%
Cash & Equivalents$3.3B+0.5%$3.4B+42.8%$2.9B+24.1%$4.0B+9.8%$3.3B-15.4%$2.4B+26.7%$2.3B-0.4%$3.7B+22.9%
Short-Term Investments$0-100.0%$85.0M-4.5%$87.0M-2.2%$89.0M-2.2%$87.0M+3.6%$89.0M+7.2%$89.0M+15.6%$91.0M+11.0%
Inventory$5.7B+7.0%$5.5B+4.4%$5.4B+6.2%$5.3B+11.2%$5.4B+1.5%$5.3B+4.9%$5.1B+1.6%$4.8B-1.4%
Accounts Receivable$3.7B+1.4%$3.7B-4.5%$3.6B-9.8%$4.0B+1.3%$3.6B-2.5%$3.9B+8.2%$4.0B+14.1%$4.0B+5.9%
Long-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Goodwill$19.3B+0.4%$19.6B+2.1%$19.2B+0.5%$19.3B+21.7%$19.3B+17.4%$19.2B+24.5%$19.1B+24.4%$15.9B+4.0%
Total Liabilities$23.8B-5.9%$23.9B-4.8%$23.3B-7.0%$25.4B+13.8%$25.3B+6.7%$25.1B+29.8%$25.1B+24.0%$22.3B+4.8%
Current Liabilities$6.5B-12.3%$6.7B-8.3%$6.3B-20.4%$7.8B+2.3%$7.4B-3.3%$7.3B+5.2%$7.9B+14.0%$7.6B-3.9%
Non-Current Liabilities$17.3B-3.2%$17.3B-3.3%$17.0B-0.9%$17.6B+19.8%$17.9B+11.5%$17.9B+43.5%$17.1B+29.2%$14.7B+9.9%
Long-Term Debt$14.2B-4.5%$14.2B-4.3%$14.2B-1.1%$14.9B+21.9%$14.8B+11.4%$14.8B+46.4%$14.4B+33.1%$12.2B+11.8%
Total Equity$23.5B+7.7%$24.0B+13.2%$23.0B+9.8%$22.4B+8.7%$21.8B+8.1%$21.2B+7.2%$20.9B+9.2%$20.6B+11.0%
Retained Earnings$21.2B+6.5%$21.8B+12.3%$20.9B+10.7%$20.5B+10.5%$20.0B+9.1%$19.4B+9.3%$18.9B+9.3%$18.5B+10.5%

SYK Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SYK quarterly cash flow statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Cash Flow$1.5B-5.1%$1.3B+13.5%$581.0M+132.4%$2.1B+11.0%$1.5B+4.5%$1.1B+75.5%$250.0M+22.5%$1.9B+26.4%
Depreciation & Amortization$397.0M-1.2%$404.0M+4.4%$397.0M+10.0%$417.0M+20.5%$402.0M+8.4%$387.0M+9.3%$361.0M+1.7%$346.0M+38.4%
Stock-Based CompensationN/AN/A$87.0M+3.6%N/AN/AN/A$84.0M-3.4%N/A
Capital Expenditures$237.0M+26.7%$202.0M+10.4%$166.0M+35.0%$268.0M+0.8%$187.0M+10.0%$183.0M+20.4%$123.0M-26.3%$266.0M+83.4%
Free Cash Flow$1.2B-9.5%$1.1B+14.1%$415.0M+226.8%$1.9B+12.6%$1.4B+3.8%$928.0M+92.9%$127.0M+243.2%$1.7B+20.4%
Investing Cash Flow-$187.0Mn/m-$639.0Mn/m-$185.0Mn/m-$305.0Mn/m-$321.0Mn/m-$104.0Mn/m-$4.1Bn/m-$303.0Mn/m
Financing Cash Flow-$1.4Bn/m-$95.0Mn/m-$1.5B-159.6%-$1.1Bn/m-$339.0M-112.8%-$989.0Mn/m$2.5Bn/m-$1.8Bn/m
Dividends Paid$338.0M+5.0%$337.0M+5.0%$337.0M+5.3%$321.0M+5.2%$322.0M+5.6%$321.0M+5.2%$320.0M+5.3%$305.0M+7.0%

Not reported in any period shown, so not listed: Share Buybacks.

SYK Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SYK quarterly financial ratios
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Gross Margin65.1%+1.5pp68.3%+4.5pp63.3%-0.5pp64.5%-0.3pp63.6%-0.4pp63.8%+0.8pp63.8%+0.3pp64.8%+1.2pp
Operating Margin15.9%-2.9pp25.2%+6.7pp15.6%+1.3ppN/A18.7%-1.0pp18.5%-0.9pp14.3%-4.3ppN/A
Net Margin11.6%-2.6pp19.4%+4.7pp12.4%+1.2pp11.8%+3.4pp14.2%-1.0pp14.7%-0.5pp11.2%-3.9pp8.5%-11.2pp
Return on Equity3.2%-0.7pp5.3%+1.1pp3.2%+0.1pp3.8%+1.1pp3.9%-0.2pp4.2%0.0pp3.1%-1.0pp2.6%-3.5pp
Return on Assets1.6%-0.2pp2.7%+0.8pp1.6%+0.2pp1.8%+0.5pp1.8%-0.1pp1.9%-0.2pp1.4%-0.6pp1.3%-1.6pp
Current Ratio2.18+0.3x2.16+0.4x2.11+0.5x1.89-0.1x1.85-0.1x1.78+0.1x1.64-0.1x1.95+0.4x
Debt-to-Equity0.60-0.1x0.59-0.1x0.62-0.1x0.66+0.1x0.680.0x0.70+0.2x0.69+0.1x0.590.0x
Liabilities-to-Equity1.01-0.1x1.00-0.2x1.01-0.2x1.13+0.1x1.160.0x1.19+0.2x1.20+0.1x1.08-0.1x
Asset Turnover0.140.0x0.140.0x0.130.0x0.150.0x0.130.0x0.130.0x0.130.0x0.150.0x
FCF Margin18.8%-3.6pp16.1%+0.7pp6.9%+4.7pp26.2%+0.3pp22.3%-1.4pp15.4%+6.5pp2.2%+1.5pp25.9%+2.1pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Stryker Corporation SYK FY2025 $25.1B $3.2B 12.9% $121.1B 69/100
Medtronic plc MDT FY2026 $36.4B $4.8B 13.2% $128.8B 63/100
Edwards Lifesciences Corp EW FY2025 $6.1B $1.1B 17.7% $60.5B 72/100
Boston Scientific Corporation BSX FY2025 $20.1B $2.9B 14.4% $63.3B 66/100
Abbott Laboratories ABT FY2025 $44.3B $6.5B 14.7% $181.0B 68/100
STERIS plc STE FY2026 $5.9B $782.3M 13.2% $25.2B 68/100

Frequently Asked Questions

Stryker Corporation (SYK) reported $25.1B in total revenue for fiscal year 2025. This represents a 11.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Stryker Corporation (SYK) revenue grew by 11.2% year-over-year, from $22.6B to $25.1B in fiscal year 2025.

Yes, Stryker Corporation (SYK) reported a net income of $3.6B over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net income of $3.2B, with a net profit margin of 12.9%.

Stryker Corporation (SYK) reported diluted earnings per share of $8.40 for fiscal year 2025. This represents a 8.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Stryker Corporation (SYK) had EBITDA of $6.5B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Stryker Corporation (SYK) had $4.0B in cash and equivalents against $14.9B in long-term debt.

Stryker Corporation (SYK) had a gross margin of 64.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Stryker Corporation (SYK) had an operating margin of 19.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Stryker Corporation (SYK) had a net profit margin of 12.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Stryker Corporation (SYK) has a return on equity of 14.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Stryker Corporation (SYK) generated $4.3B in free cash flow during fiscal year 2025. This represents a 22.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Stryker Corporation (SYK) generated $5.0B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Stryker Corporation (SYK) had $47.8B in total assets as of fiscal year 2025, including both current and long-term assets.

Stryker Corporation (SYK) invested $761.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Stryker Corporation (SYK) invested $1.6B in research and development during fiscal year 2025.

Stryker Corporation (SYK) had 383M shares outstanding as of fiscal year 2025.

Stryker Corporation (SYK) had a current ratio of 1.89 as of fiscal year 2025, which is generally considered healthy.

Stryker Corporation (SYK) had a debt-to-equity ratio of 0.66 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

Stryker Corporation (SYK) had a liabilities-to-equity ratio of 1.13 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

Stryker Corporation (SYK) had a return on assets of 6.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Stryker Corporation (SYK) trades at 33.4x earnings, its market capitalization divided by $3.6B net income, trailing 12 months to September 30, 2026. The market capitalization is $121.1B as of Nov 18, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Stryker Corporation (SYK) trades at 4.6x sales, its market capitalization divided by $26.3B revenue, trailing 12 months to September 30, 2026. The market capitalization is $121.1B as of Nov 18, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Stryker Corporation (SYK) has an Altman Z-Score of 4.49, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Stryker Corporation (SYK) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Stryker Corporation (SYK) has an earnings quality ratio of 1.55x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Stryker Corporation (SYK) has an interest coverage ratio of 8.40x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Stryker Corporation (SYK) scores 69 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top